By Fola Akinnibi ( February 27, 2017, 6:50 PM EST) -- Perrigo, amid pressure from activist hedge fund Starboard, said it will sell the royalty rights for a blockbuster multiple sclerosis drug to Royalty Pharma in a Monday deal that could be worth up to $2.85 billion, as it turns its attention toward its consumer-facing and prescription drug operations....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.